May, 2023

NanoMedSyn develops an application of its vectors on therapeutic antibodies and probes that the addition of AMFA (=M6Pn) does not alter antigen recognition or FcRn recycling.

The article is published by Journal of Controlled Release. J Control Release 2023, 358:465-475.